Clinical experience on umbilical cord mesenchymal stem cell treatment in 210 severe and critical COVID-19 cases in Turkey

OBJECTIVE: Treatment for COVID-19 is still urgent need for the critically ill and severe cases. UC-MSC administration has a therapeutic benefit for severe COVID-19 patients even in the recovery period. In this paper, we aimed to present our clinical experience with UC-MSC treatment in severe and cri...

Descripción completa

Detalles Bibliográficos
Autores principales: O. Ercelen, Nesrin, Pekkoc-Uyanik, Kubra Cigdem, Alpaydin, Nagihan, Gulay, Gokay Rasit, Simsek, Murat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8317476/
https://www.ncbi.nlm.nih.gov/pubmed/34319510
http://dx.doi.org/10.1007/s12015-021-10214-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8317476/
https://www.ncbi.nlm.nih.gov/pubmed/34319510
http://dx.doi.org/10.1007/s12015-021-10214-x

Ejemplares similares